Ryburn Pharmacy (Ripponden) Limited 04952659 false 2022-02-01 2023-01-31 2023-01-31 The principal activity of the company is that of a dispensing pharmacy. Digita Accounts Production Advanced 6.30.9574.0 true 04952659 2022-02-01 2023-01-31 04952659 2023-01-31 04952659 core:RetainedEarningsAccumulatedLosses 2023-01-31 04952659 core:ShareCapital 2023-01-31 04952659 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 04952659 core:FurnitureFittingsToolsEquipment 2023-01-31 04952659 core:LandBuildings 2023-01-31 04952659 bus:SmallEntities 2022-02-01 2023-01-31 04952659 bus:AuditExemptWithAccountantsReport 2022-02-01 2023-01-31 04952659 bus:FullAccounts 2022-02-01 2023-01-31 04952659 bus:SmallCompaniesRegimeForAccounts 2022-02-01 2023-01-31 04952659 bus:RegisteredOffice 2022-02-01 2023-01-31 04952659 bus:Director1 2022-02-01 2023-01-31 04952659 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31 04952659 core:FurnitureFittings 2022-02-01 2023-01-31 04952659 core:FurnitureFittingsToolsEquipment 2022-02-01 2023-01-31 04952659 core:LandBuildings 2022-02-01 2023-01-31 04952659 countries:England 2022-02-01 2023-01-31 04952659 2022-01-31 04952659 core:FurnitureFittingsToolsEquipment 2022-01-31 04952659 core:LandBuildings 2022-01-31 04952659 2021-02-01 2022-01-31 04952659 2022-01-31 04952659 core:RetainedEarningsAccumulatedLosses 2022-01-31 04952659 core:ShareCapital 2022-01-31 04952659 core:CurrentFinancialInstruments core:WithinOneYear 2022-01-31 04952659 core:FurnitureFittingsToolsEquipment 2022-01-31 04952659 core:LandBuildings 2022-01-31 iso4217:GBP xbrli:pure

Registration number: 04952659

Ryburn Pharmacy (Ripponden) Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 January 2023

 

Ryburn Pharmacy (Ripponden) Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 7

 

Ryburn Pharmacy (Ripponden) Limited

Balance Sheet

as at 31 January 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

36,930

43,898

Current assets

 

Stocks

63,714

68,702

Debtors

5

138,123

222,375

Cash at bank and in hand

 

671,084

599,068

 

872,921

890,145

Creditors: Amounts falling due within one year

6

(309,749)

(314,400)

Net current assets

 

563,172

575,745

Total assets less current liabilities

 

600,102

619,643

Provisions for liabilities

(3,855)

(4,621)

Net assets

 

596,247

615,022

Capital and reserves

 

Allotted, called up and fully paid share capital

100

100

Profit and loss account

596,147

614,922

Shareholders' funds

 

596,247

615,022

Registration number: 04952659

 

Ryburn Pharmacy (Ripponden) Limited

Balance Sheet

as at 31 January 2023 (continued)

For the financial year ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 17 October 2023 and signed on its behalf by:
 

.........................................
Mr J Lubera
Director

 

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2023

1

General information

The company is a private company limited by shares incorporated in England within the United Kingdom.

The company's registration number is 04952659.

The address of its registered office is:
First Floor
Rosemount House
Huddersfield Road
Elland
West Yorkshire
HX5 0EE

The principal place of business is:
Hirst Wood
Ripponden
Sowerby Bridge
West Yorkshire
HX6 4BN

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

 

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2023 (continued)

2

Accounting policies (continued)

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have been transferred to the buyer.

Government grants and other grants

Grants relating to revenue are recognised in income on a systematic basis over the periods in which the entity recognises the related costs for which the grant is intended to compensate.

A grant that becomes receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs shall be recognised in income in the period in which it becomes receivable.

Tax

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Tangible assets

Tangible assets are stated in the balance sheet at cost (or deemed cost), less any accumulated depreciation and accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2023 (continued)

2

Accounting policies (continued)

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures, fittings and equipment

15% per annum on a reducing balance basis and 33.33% per annum on a straight line basis

Leasehold property improvements

Straight line over the life of the lease

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Leases

Rentals in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year was 12 (2022 - 11).

 

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2023 (continued)

4

Tangible assets

Leasehold property improvements
£

Furniture, fittings and computer equipment
 £

Total
£

Cost

At 1 February 2022

97,911

57,947

155,858

Additions

-

249

249

At 31 January 2023

97,911

58,196

156,107

Depreciation

At 1 February 2022

63,560

48,400

111,960

Charge for the year

4,940

2,277

7,217

At 31 January 2023

68,500

50,677

119,177

Net book value

At 31 January 2023

29,411

7,519

36,930

At 31 January 2022

34,351

9,547

43,898

 

Ryburn Pharmacy (Ripponden) Limited

Notes to the Unaudited Financial Statements

for the Year Ended 31 January 2023 (continued)

5

Debtors

Current

2023
£

2022
£

Trade debtors

101,487

188,423

Prepayments

18,057

18,177

Other debtors

18,579

15,775

 

138,123

222,375

6

Creditors

2023
£

2022
£

Due within one year

Trade creditors

170,218

192,916

Directors' loan accounts

92,327

46,941

Taxation and social security

787

836

Other creditors

4,133

23,641

Accruals

5,525

5,802

Corporation tax

36,759

44,264

309,749

314,400

7

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £227,105 (2022 - £261,105). These financial commitments relate to non-cancellable operating leases and are payable over the remaining life of those leases.